» Articles » PMID: 28287622

A Codon-shuffling Method to Prevent Reversion During Production of Replication-defective Herpesvirus Stocks: Implications for Herpesvirus Vaccines

Overview
Journal Sci Rep
Specialty Science
Date 2017 Mar 14
PMID 28287622
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Herpesviruses establish life-long chronic infections that place infected hosts at risk for severe disease. Herpesvirus genomes readily undergo homologous recombination (HR) during productive replication, often leading to wild-type (WT) reversion during complementation of replication-defective and attenuated viruses via HR with the helper gene provided in trans. To overcome this barrier, we developed a synthetic-biology approach based on a technique known as codon shuffling. Computer-assisted algorithms redistribute codons in a helper gene, thereby eliminating regions of homology, while enabling manipulation of factors such as codon-pair bias and CpG content to effectively titrate helper-gene protein levels. We apply this technique to rescue the replication of a murine gammaherpesvirus engineered with a mutation in the major immediate-early transactivator protein RTA. Complementation with codon-shuffled RTA constructs did not yield any WT revertant virus, a sharp contrast to WT virus contamination frequently observed during complementation with an unmodified helper gene. We further demonstrate the importance of eliminating WT virus contamination in an animal model of gammaherpesvirus lethality. We propose complementation by codon shuffling as a means to produce replication-defective or attenuated viruses. This method has immediate utility for investigating roles of essential genes in viral replication and will better enable future development of herpesvirus vaccines.

Citing Articles

Noncanonical circRNA biogenesis driven by alpha and gamma herpesviruses.

Dremel S, Koparde V, Arbuckle J, Hogan C, Kristie T, Krug L EMBO J. 2025; .

PMID: 40033018 DOI: 10.1038/s44318-025-00398-0.


Vaccination with a Replication-Dead Murine Gammaherpesvirus Lacking Viral Pathogenesis Genes Inhibits WT Virus Infection.

Mitra D, Oldenburg D, Forrest J, Krug L bioRxiv. 2025; .

PMID: 39803443 PMC: 11722263. DOI: 10.1101/2024.11.20.624603.


Vaccination with a Replication-Dead Murine Gammaherpesvirus Lacking Viral Pathogenesis Genes Inhibits WT Virus Infection.

Mitra D, Oldenburg D, Forrest J, Krug L Viruses. 2025; 16(12.

PMID: 39772237 PMC: 11680341. DOI: 10.3390/v16121930.


A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment.

Bland W, Mitra D, Owens S, McEvoy K, Hogan C, Boccuzzi L NPJ Vaccines. 2024; 9(1):116.

PMID: 38914546 PMC: 11196663. DOI: 10.1038/s41541-024-00908-x.


The Quest for Immunity: Exploring Human Herpesviruses as Vaccine Vectors.

Kamel M, Munds R, Verma M Int J Mol Sci. 2023; 24(22).

PMID: 38003300 PMC: 10671728. DOI: 10.3390/ijms242216112.


References
1.
Belshe R, Leone P, Bernstein D, Wald A, Levin M, Stapleton J . Efficacy results of a trial of a herpes simplex vaccine. N Engl J Med. 2012; 366(1):34-43. PMC: 3287348. DOI: 10.1056/NEJMoa1103151. View

2.
Clambey E, Virgin 4th H, Speck S . Disruption of the murine gammaherpesvirus 68 M1 open reading frame leads to enhanced reactivation from latency. J Virol. 2000; 74(4):1973-84. PMC: 111675. DOI: 10.1128/jvi.74.4.1973-1984.2000. View

3.
van Dyk L, Virgin 4th H, Speck S . The murine gammaherpesvirus 68 v-cyclin is a critical regulator of reactivation from latency. J Virol. 2000; 74(16):7451-61. PMC: 112265. DOI: 10.1128/jvi.74.16.7451-7461.2000. View

4.
Barton E, Mandal P, Speck S . Pathogenesis and host control of gammaherpesviruses: lessons from the mouse. Annu Rev Immunol. 2011; 29:351-97. DOI: 10.1146/annurev-immunol-072710-081639. View

5.
Cunningham A . The herpes zoster subunit vaccine. Expert Opin Biol Ther. 2016; 16(2):265-71. DOI: 10.1517/14712598.2016.1134481. View